SCHEMBL13024751

SCHEMBL13024751

CCCCc1nc2ccc(N(C)C(=O)OCC(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.53
AGTR2 P50052 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13066108 0.90 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9593854 0.84 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL8541851 0.83 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL8543518 0.82
SCHEMBL9160015 0.82
SCHEMBL9402007 0.82
SCHEMBL9160007 0.82
SCHEMBL9379473 0.81
SCHEMBL9845839 0.81 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9845611 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7828840-B2 Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists MED INSTITUTE, INC. (US) 2010-11-09 US disclosed
US-20090177267-A1 Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2009-07-09 US disclosed